Cargando…
New Anti-Cancer Strategy to Suppress Colorectal Cancer Growth Through Inhibition of ATG4B and Lysosome Function
Autophagy inhibition has been proposed to be a potential therapeutic strategy for cancer, however, few autophagy inhibitors have been developed. Recent studies have indicated that lysosome and autophagy related 4B cysteine peptidase (ATG4B) are two promising targets in autophagy for cancer therapy....
Autores principales: | Fu, Yuanyuan, Gu, Qianqian, Luo, Li, Xu, Jiecheng, Luo, Yuping, Xia, Fan, Han, Fanghai, Hong, Liang, Yin, Xiao-Ming, Huang, Zhiying, Li, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352571/ https://www.ncbi.nlm.nih.gov/pubmed/32532053 http://dx.doi.org/10.3390/cancers12061523 |
Ejemplares similares
-
Targeting ATG4 in Cancer Therapy
por: Fu, Yuanyuan, et al.
Publicado: (2019) -
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer
por: Taraborrelli, Lucia, et al.
Publicado: (2023) -
Lysosome damage triggers direct ATG8 conjugation and ATG2 engagement via non-canonical autophagy
por: Cross, Jake, et al.
Publicado: (2023) -
Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancer
por: Zhong, Lin, et al.
Publicado: (2022) -
Suppression of ATG4B by copper inhibits autophagy and involves in Mallory body formation
por: Xia, Fan, et al.
Publicado: (2022)